Skip to content

Relationship Between Liver Cancer and Sarcopenia

The Effect of Sarcopenia on Hepatocellular Carcinoma After Hepatectomy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05339919
Enrollment
1200
Registered
2022-04-21
Start date
2020-05-01
Completion date
2025-08-28
Last updated
2022-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cancer, Sarcopenia

Keywords

Sarcopenia, Liver cancer, Hepatectomy, Short-term outcomes, Long-term outcomes

Brief summary

By tracking the short-term and long-term results of patients after hepatectomy, the difference of short-term results between patients with sarcopenia and patients without sarcopenia was analyzed, and the correlation between sarcopenia and short-term and long-term results of patients after hepatectomy was explored, so as to improve people's awareness of sarcopenia and pay attention to its prevention and treatment.

Detailed description

All implementation details are based on the newest EWGSOP definition. The investigators consecutively admitted patients the questionnaire and evaluated the assessment of muscle strength (grip strength test and chair stand test), muscle quantity (L3 plane total skeletal muscle area) and physical performance (gait test) following the F-A-C-S approach, to confirm patients with sarcopenia accurately. And by tracking the short-term and long-term outcomes of patients after hepatectomy, the differences were analyzed and the relationship between sarcopenia and liver cancer was explored.

Interventions

DIAGNOSTIC_TESTgait speed; ct scan;grip strength and chair stand test

The chair stand test was administered, and the time required for the patient to stand five times from a sitting position without using the arms was measured. CT scan was to scan the patient's third lumbar level. For the gait speed test, the time that patients spent walking 8 meters on a flat indoor floor at usual walking speed was measured.Grip strength test:the dominant hand and the nondominant hand were measured twice intermittently (kg), and the average value of 4 values was obtained.

Sponsors

Qilu Hospital of Shandong University
CollaboratorOTHER
The Second Hospital of Shandong University
CollaboratorOTHER
First Affiliated Hospital of Wenzhou Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with preoperative clinical diagnosis of liver cancer * No cancer other than liver cancer has been diagnosed * Age ≥18 years

Exclusion criteria

* Patients who could not complete the standard tests and questionnaires * Patients who did not accept liver resection after evaluation of treatment plan * Patients who had other concomitant preoperative causes of muscle weakness (injury, fracture, stroke, etc.) * Patients who missing CT data or CT scan did not reach the level of the third lumbar vertebra (L3)

Design outcomes

Primary

MeasureTime frameDescription
Short-term postoperative results3 monthsPostoperative complications;90 days readmission rate
Long-term results after operation10 yearsOverall survival; Disease free survival

Secondary

MeasureTime frameDescription
Postoperative hospitalization time2 monthsTime window from the day of operation to the day of discharge.
Hospitalization expenses2 monthsAll hospitalization expenses, including drug expenses, operation expenses, anesthesia expenses, nursing expenses and other expenses.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026